ES2950461T3 - Agente preventivo y/o terapéutico que contiene un compuesto de ácido piridilaminoacético para el tratamiento de una enfermedad que involucra una presión intraocular muy elevada - Google Patents
Agente preventivo y/o terapéutico que contiene un compuesto de ácido piridilaminoacético para el tratamiento de una enfermedad que involucra una presión intraocular muy elevada Download PDFInfo
- Publication number
- ES2950461T3 ES2950461T3 ES16821453T ES16821453T ES2950461T3 ES 2950461 T3 ES2950461 T3 ES 2950461T3 ES 16821453 T ES16821453 T ES 16821453T ES 16821453 T ES16821453 T ES 16821453T ES 2950461 T3 ES2950461 T3 ES 2950461T3
- Authority
- ES
- Spain
- Prior art keywords
- intraocular pressure
- pyridin
- therapeutic agent
- acetate
- ylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015137968 | 2015-07-09 | ||
PCT/JP2016/070110 WO2017006985A1 (fr) | 2015-07-09 | 2016-07-07 | Agent préventif et/ou thérapeutique contenant un composé d'acide aminoacétique pyridyle |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2950461T3 true ES2950461T3 (es) | 2023-10-10 |
Family
ID=57685038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES16821453T Active ES2950461T3 (es) | 2015-07-09 | 2016-07-07 | Agente preventivo y/o terapéutico que contiene un compuesto de ácido piridilaminoacético para el tratamiento de una enfermedad que involucra una presión intraocular muy elevada |
Country Status (6)
Country | Link |
---|---|
US (2) | US20180200239A1 (fr) |
EP (1) | EP3320904B1 (fr) |
JP (2) | JP7032134B2 (fr) |
ES (1) | ES2950461T3 (fr) |
TW (1) | TWI794140B (fr) |
WO (1) | WO2017006985A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019065838A1 (fr) | 2017-09-29 | 2019-04-04 | 参天製薬株式会社 | Médicament contenant un composé d'acide pyridylaminoacétique |
EP3730143A4 (fr) | 2017-12-21 | 2021-08-18 | Santen Pharmaceutical Co., Ltd. | Association de l'omidénépag |
US11666563B2 (en) | 2017-12-28 | 2023-06-06 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical preparation containing pyridyl aminoacetic acid compound |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002179694A (ja) | 1998-06-19 | 2002-06-26 | Wakamoto Pharmaceut Co Ltd | リン酸エステル誘導体及び医薬組成物 |
DK2264009T3 (en) | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
CA2757291C (fr) | 2009-03-30 | 2017-05-23 | Ube Industries, Ltd. | Composition pharmaceutique pour la prevention ou le traitement du glaucome |
JP5822840B2 (ja) | 2010-09-30 | 2015-11-24 | ダイトーケミックス株式会社 | 眼疾患処置薬 |
JP2014019650A (ja) * | 2012-07-13 | 2014-02-03 | Santen Pharmaceut Co Ltd | スルホンアミド化合物とタフルプロストの組み合わせ |
US9339496B2 (en) * | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
KR102074020B1 (ko) * | 2012-07-13 | 2020-02-05 | 산텐 세이야꾸 가부시키가이샤 | 술폰아미드 화합물의 조합 |
US20140018350A1 (en) | 2012-07-13 | 2014-01-16 | Asahi Glass Co., Ltd. | Combination of sulfonamide compound and tafluprost |
KR101858373B1 (ko) | 2014-01-10 | 2018-05-15 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물 |
EP3750541A1 (fr) * | 2014-01-10 | 2020-12-16 | Santen Pharmaceutical Co., Ltd | Préparation pharmaceutique contenant un composé d'acide pyridylaminoacétique |
AU2015205179B2 (en) | 2014-01-10 | 2019-09-19 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition containing pyridylamino acetic acid compound |
-
2016
- 2016-07-07 JP JP2017527490A patent/JP7032134B2/ja active Active
- 2016-07-07 TW TW105121523A patent/TWI794140B/zh active
- 2016-07-07 WO PCT/JP2016/070110 patent/WO2017006985A1/fr active Application Filing
- 2016-07-07 US US15/742,705 patent/US20180200239A1/en not_active Abandoned
- 2016-07-07 EP EP16821453.4A patent/EP3320904B1/fr active Active
- 2016-07-07 ES ES16821453T patent/ES2950461T3/es active Active
-
2020
- 2020-03-11 US US16/815,575 patent/US11331311B2/en active Active
- 2020-12-25 JP JP2020217086A patent/JP2021095406A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPWO2017006985A1 (ja) | 2018-04-19 |
TWI794140B (zh) | 2023-03-01 |
WO2017006985A1 (fr) | 2017-01-12 |
EP3320904A1 (fr) | 2018-05-16 |
EP3320904B1 (fr) | 2023-07-05 |
US20180200239A1 (en) | 2018-07-19 |
JP2021095406A (ja) | 2021-06-24 |
US11331311B2 (en) | 2022-05-17 |
US20200206200A1 (en) | 2020-07-02 |
JP7032134B2 (ja) | 2022-03-08 |
TW201705958A (zh) | 2017-02-16 |
EP3320904A4 (fr) | 2018-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11793798B2 (en) | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | |
ES2954412T3 (es) | Solución oftálmica | |
US11331311B2 (en) | Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound | |
JP2015147762A (ja) | ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 | |
JP2019081810A (ja) | 水性の組成物−弐− | |
KR20170093816A (ko) | 녹내장을 예방 또는 치료하기 위한 약물 요법 |